ETH Zurich's ECHO implant converts excess blood sugar into urine-excretable gluconate
CurieuxExplorer · x · 2026-11-06
ETH Zurich researchers built ECHO, an experimental wireless implant that lowers blood sugar without insulin. It uses a gold-platinum-graphite catalyst to convert excess glucose into gluconate, which kidneys excrete in urine. A continuous glucose monitor can trigger the implant via a smartphone. In diabetic mice, blood sugar normalized within 60–90 minutes, and animals showed weight loss after six weeks.
More from Embodied
- Open-source autonomous driving guide becomes free web book built in public — 4310sy · 2026-11-06
- Nearly 2-hour deep dive with Hugging Face LeRobot leads on end-to-end robot learning — yacinelearning · 2026-11-06
- Temple health wearable opens pre-orders, first 10,000 buyers get lifetime subscription-free access — abhishekcode42 · 2026-11-06
- First shipment of Autonomous's Lamp robot clears US customs, sales start Monday — dee_hw · 2026-11-06
- XPENG releases 4B visual grounding model GroundingPI as IRON robot eyes retail jobs — CyberRobooo · 2026-11-06
- Physicl raises $10M to close the sim-to-real gap for robots with a pipeline born from e-commerce — TechCrunch AI · 2026-11-06